Via Noor Nugali in arabnews.com : Last November, Selwa Al-Hazzaa, alongside her colleague Dr. Mohamed Khuthaila and a medical team consisting of entirely of Saudis, put the Kingdom on the map as the first country in the Middle East, and the 5th globally, to utilize LUXTURNA, the first USA FDA-approved gene therapy treatment for any genetic disorder to treat blindness in children.
